HEADER IMMUNE SYSTEM 19-NOV-07 2VH5 TITLE CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV (DISULFIDE FREE MUTANT) TITLE 2 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTI-RAS FV HEAVY CHAIN; COMPND 3 CHAIN: H; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ANTI-RAS FV LIGHT CHAIN; COMPND 7 CHAIN: L; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: GTPASE HRAS; COMPND 11 CHAIN: R; COMPND 12 FRAGMENT: RESIDUES 1-166; COMPND 13 SYNONYM: TRANSFORMING PROTEIN P21, P21RAS, H-RAS-1, C-H-RAS, HA-RAS, COMPND 14 H-RAS ONCOPROTEIN, TRANSFORMING PROTEIN P21; COMPND 15 ENGINEERED: YES; COMPND 16 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PRK-HISTEV-VH-RAS-VL; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PRK-HISTEV-VH-RAS-VL; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 19 ORGANISM_COMMON: HUMAN; SOURCE 20 ORGANISM_TAXID: 9606; SOURCE 21 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 22 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 23 EXPRESSION_SYSTEM_VARIANT: C41; SOURCE 24 EXPRESSION_SYSTEM_PLASMID: PRK-HISTEV-VH-RAS-VL KEYWDS IMMUNOGLOBULIN DOMAIN, SIGNALING PROTEIN/IMMUNE SYSTEM, METHYLATION, KEYWDS 2 PRENYLATION, LIPOPROTEIN, GTP-BINDING, SIGNAL TRANSDUCTION, KEYWDS 3 NUCLEOTIDE- BINDING, DISEASE MUTATION, NUCLEOTIDE-BINDING, IMMUNE KEYWDS 4 SYSTEM, MEMBRANE, ONCOGENE, ANTIBODY, PALMITATE, INTRABODY, PROTO- KEYWDS 5 ONCOGENE, CANCER THERAPY, GOLGI APPARATUS EXPDTA X-RAY DIFFRACTION AUTHOR T.TANAKA,R.L.WILLIAMS,T.H.RABBITTS REVDAT 4 24-JAN-18 2VH5 1 SOURCE REVDAT 3 24-FEB-09 2VH5 1 VERSN REVDAT 2 19-FEB-08 2VH5 1 JRNL REVDAT 1 22-JAN-08 2VH5 0 JRNL AUTH T.TANAKA,T.H.RABBITTS JRNL TITL FUNCTIONAL INTRACELLULAR ANTIBODY FRAGMENTS DO NOT REQUIRE JRNL TITL 2 INVARIANT INTRA-DOMAIN DISULFIDE BONDS. JRNL REF J.MOL.BIOL. V. 376 749 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18187153 JRNL DOI 10.1016/J.JMB.2007.11.085 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.TANAKA,R.L.WILLIAMS,T.H.RABBITTS REMARK 1 TITL TUMOUR PREVENTION BY A SINGLE ANTIBODY DOMAIN TARGETING THE REMARK 1 TITL 2 INTERACTION OF SIGNAL TRANSDUCTION PROTEINS WITH RAS. REMARK 1 REF EMBO J. V. 26 3250 2007 REMARK 1 REFN ISSN 0261-4189 REMARK 1 PMID 17568777 REMARK 1 DOI 10.1038/SJ.EMBOJ.7601744 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 11076 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.291 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 586 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.77 REMARK 3 REFLECTION IN BIN (WORKING SET) : 802 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE SET COUNT : 53 REMARK 3 BIN FREE R VALUE : 0.3970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3003 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 36 REMARK 3 SOLVENT ATOMS : 42 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.35000 REMARK 3 B22 (A**2) : 1.17000 REMARK 3 B33 (A**2) : 0.18000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.422 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.332 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 31.530 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.914 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.844 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3092 ; 0.011 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4192 ; 1.387 ; 1.964 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 381 ; 6.408 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 141 ;33.528 ;23.830 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 519 ;18.283 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;16.017 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 467 ; 0.096 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2325 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1329 ; 0.213 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2043 ; 0.305 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 121 ; 0.147 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 48 ; 0.370 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.614 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1953 ; 0.360 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3062 ; 0.609 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1320 ; 1.009 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1130 ; 1.624 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : R 1 R 1000 REMARK 3 ORIGIN FOR THE GROUP (A): -.4628 19.1436 33.6485 REMARK 3 T TENSOR REMARK 3 T11: -.1203 T22: .0161 REMARK 3 T33: -.1241 T12: -.0109 REMARK 3 T13: .0049 T23: -.0525 REMARK 3 L TENSOR REMARK 3 L11: 2.1907 L22: 1.8448 REMARK 3 L33: 3.0986 L12: .4871 REMARK 3 L13: -.3261 L23: -.3998 REMARK 3 S TENSOR REMARK 3 S11: .0102 S12: -.0044 S13: .1231 REMARK 3 S21: .2215 S22: -.0001 S23: .1489 REMARK 3 S31: -.0141 S32: -.2647 S33: -.0101 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : H 1 H 1000 REMARK 3 ORIGIN FOR THE GROUP (A): 12.2156 10.8085 5.5954 REMARK 3 T TENSOR REMARK 3 T11: -.0756 T22: -.1470 REMARK 3 T33: -.1121 T12: .0150 REMARK 3 T13: -.0019 T23: .0087 REMARK 3 L TENSOR REMARK 3 L11: 3.0386 L22: 2.3655 REMARK 3 L33: 4.1097 L12: -.1673 REMARK 3 L13: -1.0690 L23: 1.1457 REMARK 3 S TENSOR REMARK 3 S11: .1012 S12: -.1124 S13: .0077 REMARK 3 S21: -.2602 S22: -.0389 S23: -.0956 REMARK 3 S31: .1507 S32: .2824 S33: -.0622 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : L 1 L 1000 REMARK 3 ORIGIN FOR THE GROUP (A): 4.8661 30.6635 -.5587 REMARK 3 T TENSOR REMARK 3 T11: .0024 T22: -.1301 REMARK 3 T33: .1369 T12: .0338 REMARK 3 T13: .0503 T23: .0507 REMARK 3 L TENSOR REMARK 3 L11: 6.3357 L22: 6.7324 REMARK 3 L33: 4.6949 L12: -.2483 REMARK 3 L13: -2.5805 L23: -.4033 REMARK 3 S TENSOR REMARK 3 S11: .2651 S12: .2582 S13: 1.1452 REMARK 3 S21: -.4153 S22: .1713 S23: -.1360 REMARK 3 S31: -.3756 S32: -.3401 S33: -.4364 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2VH5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1290034455. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-DEC-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC CONFOCAL OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11682 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 42.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN WAS CRYSTALLIZED FROM 17-18 % REMARK 280 PEG3350, 320 MM ZINC ACETATE, 100 MM SODIUM CACODYLATE, PH 5.8, REMARK 280 0.03 % DICHLOROMETHANE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 37.93150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.70150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 37.93150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.70150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, R REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN R, GLY 12 TO VAL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU H 1 NE2 HIS R 166 4556 1.97 REMARK 500 CE1 HIS R 27 OE2 GLU R 98 4556 2.05 REMARK 500 OE2 GLU R 31 OD2 ASP R 107 4556 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP R 108 CB - CG - OD1 ANGL. DEV. = 6.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS H 43 -169.76 -101.73 REMARK 500 SER H 55 -2.81 72.59 REMARK 500 THR H 91 109.47 -58.26 REMARK 500 LEU L 13 114.21 -174.57 REMARK 500 THR L 22 67.08 82.93 REMARK 500 SER L 32 79.78 34.06 REMARK 500 SER L 33 -20.71 73.46 REMARK 500 ALA L 53 -56.24 72.16 REMARK 500 ASN R 26 18.94 54.70 REMARK 500 ILE R 36 -65.04 -94.59 REMARK 500 ASP R 108 61.39 -105.34 REMARK 500 LYS R 117 33.26 73.32 REMARK 500 ARG R 149 -1.08 78.62 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG R1168 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GTP R1167 O2G REMARK 620 2 THR R 35 OG1 82.8 REMARK 620 3 GTP R1167 O1B 88.6 169.9 REMARK 620 4 SER R 17 OG 164.0 94.8 94.9 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GTP R1167 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG R1168 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN H1115 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN H1116 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN R1169 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 121P RELATED DB: PDB REMARK 900 RELATED ID: 1AA9 RELATED DB: PDB REMARK 900 HUMAN C-HA-RAS(1-171)(DOT)GDP, NMR, MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1AGP RELATED DB: PDB REMARK 900 RELATED ID: 1BKD RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN H-RAS WITH HUMAN SOS-1 REMARK 900 RELATED ID: 1CRR RELATED DB: PDB REMARK 900 RELATED ID: 1CTQ RELATED DB: PDB REMARK 900 STRUCTURE OF P21RAS IN COMPLEX WITH GPPNHP AT 100 K REMARK 900 RELATED ID: 1GNR RELATED DB: PDB REMARK 900 RELATED ID: 1IAQ RELATED DB: PDB REMARK 900 C-H-RAS P21 PROTEIN MUTANT WITH THR 35 REPLACED BY SER(T35S) REMARK 900 COMPLEXED WITH GUANOSINE-5'-[B,G-IMIDO] TRIPHOSPHATE REMARK 900 RELATED ID: 1JAI RELATED DB: PDB REMARK 900 H-RAS P21 PROTEIN MUTANT G12P, COMPLEXED WITHGUANOSINE-5'-[BETA, REMARK 900 GAMMA-METHYLENE] TRIPHOSPHATEAND MANGANESE REMARK 900 RELATED ID: 1LF0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RASA59G IN THE GTP- BOUND FORM REMARK 900 RELATED ID: 1NVU RELATED DB: PDB REMARK 900 STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OFTHE RAS- REMARK 900 SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS REMARK 900 RELATED ID: 1NVV RELATED DB: PDB REMARK 900 STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OFTHE RAS- REMARK 900 SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS REMARK 900 RELATED ID: 1NVW RELATED DB: PDB REMARK 900 STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OFTHE RAS- REMARK 900 SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS REMARK 900 RELATED ID: 1NVX RELATED DB: PDB REMARK 900 STRUCTURAL EVIDENCE FOR FEEDBACK ACTIVATION BY RASGTP OFTHE RAS- REMARK 900 SPECIFIC NUCLEOTIDE EXCHANGE FACTOR SOS REMARK 900 RELATED ID: 1P2S RELATED DB: PDB REMARK 900 H-RAS 166 IN 50% 2,2,2 TRIFLOUROETHANOL REMARK 900 RELATED ID: 1PLK RELATED DB: PDB REMARK 900 RELATED ID: 1QRA RELATED DB: PDB REMARK 900 STRUCTURE OF P21RAS IN COMPLEX WITH GTP AT 100 K REMARK 900 RELATED ID: 1RVD RELATED DB: PDB REMARK 900 H-RAS COMPLEXED WITH DIAMINOBENZOPHENONE-BETA ,GAMMA-IMIDO- GTP REMARK 900 RELATED ID: 1WQ1 RELATED DB: PDB REMARK 900 RAS-RASGAP COMPLEX REMARK 900 RELATED ID: 1XCM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE GPPNHP-BOUND H- RAS G60A MUTANT REMARK 900 RELATED ID: 1XD2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF A TERNARY RAS:SOS:RAS *GDP COMPLEX REMARK 900 RELATED ID: 1ZVQ RELATED DB: PDB REMARK 900 STRUCTURE OF THE Q61G MUTANT OF RAS IN THE GDP-BOUND FORM REMARK 900 RELATED ID: 1ZW6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE GTP-BOUND FORM OF RASQ61G REMARK 900 RELATED ID: 2C5L RELATED DB: PDB REMARK 900 STRUCTURE OF PLC EPSILON RAS ASSOCIATION DOMAIN WITH HRAS REMARK 900 RELATED ID: 2CL6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN REMARK 900 COMPLEX WITH S- CAGED GTP REMARK 900 RELATED ID: 2CL7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN REMARK 900 COMPLEX WITH GTP REMARK 900 RELATED ID: 2CLC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN REMARK 900 COMPLEX WITH GTP ( 2) REMARK 900 RELATED ID: 2CLD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN REMARK 900 COMPLEX WITH GDP ( 2) REMARK 900 RELATED ID: 1CLU RELATED DB: PDB REMARK 900 H-RAS COMPLEXED WITH DIAMINOBENZOPHENONE-BETA ,GAMMA-IMIDO- GTP REMARK 900 RELATED ID: 1CRP RELATED DB: PDB REMARK 900 RELATED ID: 1CRQ RELATED DB: PDB REMARK 900 RELATED ID: 1GNP RELATED DB: PDB REMARK 900 RELATED ID: 1GNQ RELATED DB: PDB REMARK 900 RELATED ID: 1HE8 RELATED DB: PDB REMARK 900 RAS G12V - PI 3-KINASE GAMMA COMPLEX REMARK 900 RELATED ID: 1IOZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE C-HA-RAS PROTEIN PREPARED BY THECELL-FREE REMARK 900 SYNTHESIS REMARK 900 RELATED ID: 1JAH RELATED DB: PDB REMARK 900 H-RAS P21 PROTEIN MUTANT G12P, COMPLEXED WITHGUANOSINE-5'-[BETA, REMARK 900 GAMMA-METHYLENE] TRIPHOSPHATE ANDMAGNESIUM REMARK 900 RELATED ID: 1K8R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RAS-BRY2RBD COMPLEX REMARK 900 RELATED ID: 1LF5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF RASA59G IN THE GDP- BOUND FORM REMARK 900 RELATED ID: 1LFD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ACTIVE RAS PROTEIN COMPLEXED WITHTHE RAS- REMARK 900 INTERACTING DOMAIN OF RALGDS REMARK 900 RELATED ID: 1P2T RELATED DB: PDB REMARK 900 H-RAS 166 IN AQUEOUS MOTHER LIQOUR, RT REMARK 900 RELATED ID: 1P2U RELATED DB: PDB REMARK 900 H-RAS IN 50% ISOPROPANOL REMARK 900 RELATED ID: 1P2V RELATED DB: PDB REMARK 900 H-RAS 166 IN 60 % 1,6 HEXANEDIOL REMARK 900 RELATED ID: 1PLL RELATED DB: PDB REMARK 900 RELATED ID: 1Q21 RELATED DB: PDB REMARK 900 RELATED ID: 1XJ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE GDP-BOUND FORM OF THE RASG60AMUTANT REMARK 900 RELATED ID: 221P RELATED DB: PDB REMARK 900 RELATED ID: 2CE2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN REMARK 900 COMPLEX WITH GDP REMARK 900 RELATED ID: 2CL0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RAS P21 IN REMARK 900 COMPLEX WITH GPPNHP REMARK 900 RELATED ID: 2GDP RELATED DB: PDB REMARK 900 RELATED ID: 2Q21 RELATED DB: PDB REMARK 900 RELATED ID: 2UZI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HRAS(G12V) - ANTI-RAS FV COMPLEX REMARK 900 RELATED ID: 4Q21 RELATED DB: PDB REMARK 900 RELATED ID: 5P21 RELATED DB: PDB REMARK 900 RELATED ID: 621P RELATED DB: PDB REMARK 900 RELATED ID: 6Q21 RELATED DB: PDB REMARK 900 RELATED ID: 821P RELATED DB: PDB REMARK 900 RELATED ID: 2EVW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF A FLUORESCENT FORM OF H-RASP21 IN REMARK 900 COMPLEX WITH R-CAGED GTP REMARK 900 RELATED ID: 421P RELATED DB: PDB REMARK 900 RELATED ID: 521P RELATED DB: PDB REMARK 900 RELATED ID: 721P RELATED DB: PDB DBREF 2VH5 H 1 114 PDB 2VH5 2VH5 1 114 DBREF 2VH5 L 4 107 PDB 2VH5 2VH5 4 107 DBREF 2VH5 R 1 166 UNP P01112 RASH_HUMAN 1 166 SEQADV 2VH5 VAL R 12 UNP P01112 GLY 12 ENGINEERED MUTATION SEQRES 1 H 114 GLU VAL GLN LEU LEU GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 114 PRO GLY GLY SER LEU ARG LEU SER ALA ALA ALA SER GLY SEQRES 3 H 114 PHE THR PHE SER THR PHE SER MET ASN TRP VAL ARG GLN SEQRES 4 H 114 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER TYR ILE SER SEQRES 5 H 114 ARG THR SER LYS THR ILE TYR TYR ALA ASP SER VAL LYS SEQRES 6 H 114 GLY ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR SEQRES 7 H 114 LEU TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 H 114 ALA VAL TYR TYR VAL ALA ARG GLY ARG PHE PHE ASP TYR SEQRES 9 H 114 TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 1 L 104 ILE GLN MET THR GLN SER PRO SER SER LEU SER ALA SER SEQRES 2 L 104 VAL GLY ASP ARG VAL THR ILE THR VAL ARG ALA SER GLN SEQRES 3 L 104 SER ILE SER SER TYR LEU ASN TRP TYR GLN GLN LYS PRO SEQRES 4 L 104 GLY GLU ALA PRO LYS LEU LEU ILE TYR SER ALA SER VAL SEQRES 5 L 104 LEU GLN SER GLY VAL PRO SER ARG PHE SER GLY SER GLY SEQRES 6 L 104 SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU GLN SEQRES 7 L 104 PRO GLU ASP PHE ALA THR TYR TYR ALA GLN GLN SER VAL SEQRES 8 L 104 MET ILE PRO MET THR PHE GLY GLN GLY THR LYS VAL GLU SEQRES 1 R 166 MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA VAL GLY SEQRES 2 R 166 VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE GLN ASN SEQRES 3 R 166 HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU ASP SER SEQRES 4 R 166 TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR CYS LEU SEQRES 5 R 166 LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU TYR SER SEQRES 6 R 166 ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU GLY PHE SEQRES 7 R 166 LEU CYS VAL PHE ALA ILE ASN ASN THR LYS SER PHE GLU SEQRES 8 R 166 ASP ILE HIS GLN TYR ARG GLU GLN ILE LYS ARG VAL LYS SEQRES 9 R 166 ASP SER ASP ASP VAL PRO MET VAL LEU VAL GLY ASN LYS SEQRES 10 R 166 CYS ASP LEU ALA ALA ARG THR VAL GLU SER ARG GLN ALA SEQRES 11 R 166 GLN ASP LEU ALA ARG SER TYR GLY ILE PRO TYR ILE GLU SEQRES 12 R 166 THR SER ALA LYS THR ARG GLN GLY VAL GLU ASP ALA PHE SEQRES 13 R 166 TYR THR LEU VAL ARG GLU ILE ARG GLN HIS HET ZN H1115 1 HET ZN H1116 1 HET ZN R1169 1 HET GTP R1167 32 HET MG R1168 1 HETNAM ZN ZINC ION HETNAM GTP GUANOSINE-5'-TRIPHOSPHATE HETNAM MG MAGNESIUM ION FORMUL 4 ZN 3(ZN 2+) FORMUL 7 GTP C10 H16 N5 O14 P3 FORMUL 8 MG MG 2+ FORMUL 9 HOH *42(H2 O) HELIX 1 1 THR H 28 PHE H 32 5 5 HELIX 2 2 ASP H 62 VAL H 64 5 3 HELIX 3 3 ARG H 87 THR H 91 5 5 HELIX 4 4 GLY R 15 ASN R 26 1 12 HELIX 5 5 GLN R 61 ALA R 66 5 6 HELIX 6 6 MET R 67 GLY R 75 1 9 HELIX 7 7 ASN R 86 ASP R 105 1 20 HELIX 8 8 GLU R 126 GLY R 138 1 13 HELIX 9 9 GLY R 151 HIS R 166 1 16 SHEET 1 HA 4 GLN H 3 SER H 7 0 SHEET 2 HA 4 LEU H 18 SER H 25 -1 O SER H 21 N SER H 7 SHEET 3 HA 4 THR H 78 MET H 83 -1 O LEU H 79 N ALA H 22 SHEET 4 HA 4 PHE H 68 ASP H 73 -1 O THR H 69 N GLN H 82 SHEET 1 HB 6 GLY H 10 VAL H 12 0 SHEET 2 HB 6 THR H 109 VAL H 113 1 O LEU H 110 N GLY H 10 SHEET 3 HB 6 ALA H 92 ARG H 98 -1 O ALA H 92 N VAL H 111 SHEET 4 HB 6 MET H 34 GLN H 39 -1 O ASN H 35 N ALA H 97 SHEET 5 HB 6 GLU H 46 ILE H 51 -1 O GLU H 46 N ARG H 38 SHEET 6 HB 6 ILE H 58 TYR H 60 -1 O TYR H 59 N TYR H 50 SHEET 1 LA 4 MET L 6 SER L 9 0 SHEET 2 LA 4 VAL L 21 ALA L 27 -1 O THR L 24 N SER L 9 SHEET 3 LA 4 ASP L 72 ILE L 77 -1 O PHE L 73 N VAL L 25 SHEET 4 LA 4 PHE L 64 SER L 69 -1 O SER L 65 N THR L 76 SHEET 1 LB 6 SER L 12 SER L 14 0 SHEET 2 LB 6 THR L 104 GLU L 107 1 O LYS L 105 N LEU L 13 SHEET 3 LB 6 THR L 87 GLN L 92 -1 O TYR L 88 N THR L 104 SHEET 4 LB 6 LEU L 35 GLN L 40 -1 O ASN L 36 N GLN L 91 SHEET 5 LB 6 LYS L 47 TYR L 51 -1 O LYS L 47 N GLN L 39 SHEET 6 LB 6 VAL L 55 LEU L 56 -1 O VAL L 55 N TYR L 51 SHEET 1 RA 6 GLU R 37 ILE R 46 0 SHEET 2 RA 6 GLU R 49 THR R 58 -1 O GLU R 49 N ILE R 46 SHEET 3 RA 6 GLU R 3 VAL R 9 1 O TYR R 4 N ASP R 54 SHEET 4 RA 6 GLY R 77 ALA R 83 1 O GLY R 77 N VAL R 7 SHEET 5 RA 6 MET R 111 ASN R 116 1 O VAL R 112 N CYS R 80 SHEET 6 RA 6 TYR R 141 GLU R 143 1 O ILE R 142 N GLY R 115 LINK ZN ZN H1115 OD1 ASP H 73 1555 1555 2.24 LINK ZN ZN H1116 OD2 ASP H 62 1555 1555 2.13 LINK MG MG R1168 O2G GTP R1167 1555 1555 1.89 LINK MG MG R1168 OG1 THR R 35 1555 1555 1.90 LINK MG MG R1168 O1B GTP R1167 1555 1555 1.82 LINK MG MG R1168 OG SER R 17 1555 1555 1.73 CISPEP 1 PRO H 41 GLY H 42 0 -22.70 CISPEP 2 SER L 9 PRO L 10 0 4.53 CISPEP 3 VAL L 21 THR L 22 0 10.13 CISPEP 4 ILE L 96 PRO L 97 0 2.52 SITE 1 AC1 23 GLY R 13 VAL R 14 GLY R 15 LYS R 16 SITE 2 AC1 23 SER R 17 ALA R 18 PHE R 28 VAL R 29 SITE 3 AC1 23 ASP R 30 TYR R 32 PRO R 34 THR R 35 SITE 4 AC1 23 GLY R 60 ASN R 116 LYS R 117 ASP R 119 SITE 5 AC1 23 LEU R 120 SER R 145 ALA R 146 MG R1168 SITE 6 AC1 23 HOH R2005 HOH R2022 HOH R2023 SITE 1 AC2 3 SER R 17 THR R 35 GTP R1167 SITE 1 AC3 2 ASP H 73 SER H 75 SITE 1 AC4 1 ASP H 62 SITE 1 AC5 1 HIS R 166 CRYST1 75.863 85.403 63.084 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013182 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011709 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015852 0.00000